The ETERNAL project just celebrated its first birthday. During that time the project partners have established strong and effective reporting structures and working relationships to deliver on an ambitious programme bringing together extensive industrial case studies scaling up sustainable, green pharmaceutical manufacturing processes with new insight into the environmental and ecotoxicological impacts of drug manufacture and consumption, to better understand how the one can maximally improve the other. Project coordinator Pablo Ferrer Pérez reflects on some of the significant first steps taken during this time and the foundations that have been laid for future success.

ETERNAL is actively seeking to reach out to people working right across the pharmaceutical value chain from drug development and design, through manufacture, distribution, healthcare, disposal and public utilities to understand where we can prioritise action promoting change for sustainable healthcare. You can help by sharing your views in our short stakeholder survey.

Meet the people working in ETERNAL to translate the alignment of ETERNAL’s goals and AstraZeneca’s sustainability strategy into demonstrable developments in the use of membranes in pharmaceutical processing to recover and purify solvents with energy efficiency, remove impurities, and reduce ecotoxicity of waste streams.